ArticlePulmonary therapy2022

Treatment with the P2X3-Receptor Antagonist Gefapixant for Acute Cough in Induced Viral Upper Respiratory Tract Infection: A Phase 2a, Randomized, Placebo-Controlled Trial.

Jaclyn A Smith et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.